Social Media Ideas for Johnson & Johnson

Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future

Johnson & Johnson's new drugs may offset declining sales due to patent-protection losses.

<![CDATA[M&A Roundup: Johnson & Johnson Collaborates with Sail Biomedicines, Processa Pharmaceuticals Acquire...

Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?

Johnson & Johnson offers $5.5B talc lawsuit settlement

Johnson & Johnson proposes a $5.5B settlement to resolve 76,000 talc lawsuits alleging baby powder caused ovarian cancer. The post Johnson & Johnson offers $5.5B talc lawsu...

Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff?

J&J Says No To Reviving Stelara Case

Johnson & Johnson has asked the Fourth Circuit not to revive CareFirst's antitrust suit alleging the company tried to monopolize the market for the immunosuppressive drug Stela...

AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.

Johnson & Johnson Offers $5.5 Billion to Settle Talc Lawsuits

Johnson & Johnson's proposed $5.5 billion talc settlement covers 76,000 ovarian cancer claims and requires 95% claimant approval to take effect The post Johnson & Johnson O...

Johnson & Johnson Announces $5.5 Billion Settlement of Talc Lawsuits

Johnson & Johnson said on Monday it would pay $5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer, in a...

Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight

Johnson & Johnson has agreed to pay $5.5 billion to tie up remaining lawsuits that claim its talc products caused ovarian cancer. The drugmaker, which has been fighting talc...

I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now

The company is firing on all cylinders.

Johnson & Johnson offers $5.5B to settle baby powder cancer lawsuits

The New Jersey-based drugmaker has been fighting talc-related lawsuits for more than a decade and said the settlement was a last-ditch effort to put the matter to bed.

Johnson & Johnson offers $5.5 billion to settle talc lawsuits

US pharmaceutical giant Johnson & Johnson has offered $5.5 billion to settle tens of thousands of lawsuits claiming that its talcum powder products caused ovarian cancer, the c...

Johnson & Johnson to pay £4.1bn to settle lawsuits alleging talc products cause cancer

The New-Jersey-based company - well-known for its baby powder - has proposed a settlement in an attempt to turn the page on the long-running legal battle.

J&J Says Cancer Drug Study Sinks Bayer's False Ad Claims

Johnson & Johnson told a New York federal court that a peer-reviewed scientific journal's publication of a study on the active ingredient in its prostate cancer drug must end B...

Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit

Johnson & Johnson (NYSE: JNJ) will present at the Deutsche Bank 2026 Healthcare Summit on Thursday, September 17 th, 2026. Management will participate in a Fireside Chat at 12:...

Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report?

J&J has more than 28 sources of blockbuster revenue.

Johnson & Johnson offers $5.5 billion to settle remaining lawsuits over talc products linked to cancer

Johnson & Johnson has agreed to pay $5.5 billion to tie up remaining lawsuits that claim its talc products caused ovarian cancer. The drugmaker, which has been fighting talc...

I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now

Looking for a dividend stock you can sleep well owning? Here's why Johnson & Johnson could be the long-term healthcare anchor your portfolio needs.

Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit

Landmark deal covers about 76,000 claims and could end contentious, decade-long legal battleJohnson & Johnson said it would pay an estimated $5.5bn to resolve tens of thousands...

Johnson & Johnson to pay $5.5 bln to settle talc-related cancer lawsuits

Johnson & Johnson offers $5.5 million to settle about 76000 baby powder cancer claims

Johnson & Johnson (J&J) has offered to pay as much as $5.5bn (4.14bn) to resol

Johnson & Johnson offers $5.5bn to settle lawsuits, as it rejects claims talc products caused cancer

J&J said the settlement covers around 76,000 claims, representing nearly all remaining talc claims.

Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight

(AP) — Johnson & Johnson has agreed to pay $5.5 billion to tie up remaining lawsuits that claim its talc products caused ovarian cancer. The...